Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+0.4%
5Y CAGR+26.8%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+0.4%/yr
Annual compound
5Y CAGR
+26.8%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$70.78M-3.9%
2024$73.67M+25.5%
2023$58.68M-16.1%
2022$69.95M+39.7%
2021$50.09M+131.6%
2020$21.63M+117.7%
2019$9.94M-